PubMed Health⌕ Search

Biomedical subjects

W C Hooper

Publications and source records attributed to W C Hooper.

66 records · Page 4Linked to original sources

Studies of myeloperoxidase gene expression at the cellular level by in situ hybridization.

Recent studies have demonstrated myeloperoxidase (MPO) gene expression during granulocytic differentiation. Since these studies have been done exclusively by Northern and dot blot analysis and frequently with mixed populations of cells, quantitative changes in gene expression for particular populations of cells are difficult to assess. We therefore examined MPO expression at the cellular level in various normal and malignant hematopoietic cells by the in situ hybridization (ISH) technique. Using this approach, we demonstrated that inducing the promyelocytic HL-60 cell line to differentiate along either monocytic or granulocytic pathways decreases MPO mRNA expression. Similarly, when ISH was performed on normal bone marrow, relatively high levels of MPO mRNA were detected in myeloblasts, promyelocytes, and early eosinophilic precursors, whereas the expression was markedly decreased in more advanced stages of myeloid differentiation. These findings agree with the known decrease in MPO protein synthesis observed during granulocytic differentiation and suggest that regulation of MPO protein synthesis occurs at the level of MPO mRNA expression. We conclude by showing that ISH can detect MPO mRNA in myeloblasts of patients with acute leukemia and can be a potentially useful technique in the study of myeloid differentiation in acute leukemias.

Adolescent↗

Transforming growth factor-beta induces hemoglobin synthesis in a human erythroleukemia cell line.

We have examined the effects of TGF beta 1 and TGF beta 2 on the HEL human erythroleukemia cell line. It was observed that TGF beta 1 and 2 induced hemoglobin synthesis in these cells without causing a significant negative effect on cell proliferation. The cell surface markers glycophorin A and transferrin receptor that are associated with erythroid differentiation were also increased. This cell line may provide a model system in which to study the regulation of globin gene expression by a physiological growth factor known to act on hemopoietic cells.

Blotting, Northern↗

Differential responsiveness to phorbol esters correlates with differential expression of protein kinase C in KG-1 and KG-1a human myeloid leukemia cells.

The KG-1 myeloid leukemia cell line differentiates into macrophages in response to 12-O-tetradecanoylphorbol 13-acetate (TPA), while its spontaneous variant, the KG-1a cell line, is resistant to the differentiative effects of TPA. To determine the mechanism underlying these differential responses to TPA, experiments were performed to determine the relative numbers of TPA binding sites, protein kinase C (PKC) enzyme activity levels, PKC translocation responses and PKC gene expression in these cell lines. KG-1a cells exhibited 40% fewer high affinity binding sites for TPA than KG-1 cells. Although PKC translocation from cytosol to the membrane fraction was observed in both cell types, total PKC activity, measured in vitro using type III-S histone as substrate, was reduced by 70% in KG-1a cells. These biochemical differences between the parental line and the phorbol ester non-responsive variant were correlated with the depressed level of PKC-beta RNA abundance in KG-1a cells. Both lines expressed PKC-alpha RNA at comparable levels. Chronic exposure to TPA resulted in down-regulation of PKC enzyme activity in both cell lines, and a selective decrease in PKC-beta RNA transcripts in both cell types. In contrast, chronic TPA treatment had no effect on the levels of PKC-alpha RNA in KG-1 and KG-1a cells. Our results indicate a correlation between the level of PKC-beta expression and the responsiveness of myeloid lineage precursor cells to the differentiative effects of TPA.

Caenorhabditis elegans Proteins↗

T-cell non-Hodgkin lymphoma in human immunodeficiency virus-1-infected individuals.

We present two patients with human immunodeficiency virus-1 (HIV-1) infection in whom T-cell non-Hodgkin lymphoma developed, based on pathologic diagnosis, immunophenotyping, and T-cell receptor gene rearrangement. Both cases were positive for human immunodeficiency virus-1 by enzyme-linked immunosorbent assay and immunoblot methods. Histologic sections from each patient showed a high-grade pleomorphic T-cell non-Hodgkin lymphoma, and immunophenotyping demonstrated a prevalence of reactivity for CD4 (helper) over CD8 (suppressor) antigens. T-cell receptor beta-chain gene rearrangement studies revealed a rearranged pattern with either the HindIII or BamHI enzymes, whereas immunoglobulin heavy chain genes retained a germ-line configuration. Viral sequences specific for human T-cell leukemia virus-I, human T-cell leukemia virus-II, or HIV-1 were not detected. Thus, although rare, T-cell non-Hodgkin lymphoma may be observed in HIV-1-infected individuals.

Acquired Immunodeficiency Syndrome↗

Oncogene expression in T-cell lymphoproliferative disorders.

We have investigated the expression of oncogenes and other related genes in eleven patients with T-cell lymphoproliferative disorders and ten patients with other hematologic malignancies. The phenotypes of the T-cell disorders were determined using monoclonal antibodies specific for helper or suppressor subsets. RNA preparations were isolated from peripheral blood mononuclear cells and/or lymph node sections, 5'-end labeled with gamma-32P-ATP, and hybridized under stringent conditions to an excess of nitrocellulose-bound specific cloned DNA; autoradiographs were analysed by microdensitometry. Results revealed increased expression of K-ras, v-fps, transferrin receptor, alpha-tubulin and alpha-interferon in at least five of six helper T-cell lymphoproliferative disorders, while five of five suppressor T-cell disorders demonstrated levels of hybridization to these clones no higher than background. However, studies of T-suppressor disorders demonstrated enhanced levels of beta-interferon-specific RNA in five of five patients, an increase apparent in three of six T-helper chronic lymphoproliferative disorders. These results demonstrate different patterns of gene expression evident in T-helper and T-suppressor abnormalities.

Adult↗

Phenotypic changes associated with chemically induced differentiation of a hairy cell leukemia cell line.

In vitro chemically induced differentiation of the JOK-1 cell line, derived from a patient with hairy cell leukemia, has been studied. Non-induced JOK-1 cells expressed sIgM, B-1, CALLA, Ia, and C3 receptors. Following exposure to 2% DMSO, or 100 ng/ml 12-O-tetradecanoyl-phorbol-13-acetate (TPA), the cells underwent a phenotypic change from lymphoblastoid to monocytoid. In the presence of TPA, they became adherent and developed dendritic processes. Associated with these changes was a decrease in sIgM and CALLA and variable expression of C3 receptors. No monocyte/macrophage-associated antigens were detected. These results suggest that the JOK-1 cell line may have a limited ability to differentiate but is not mature enough to complete the differentiation process.

Antigens, Surface↗

Effect of dimethylsulfoxide and hexamethylene bisacetamide on the JOK-1 hairy cell leukemia derived cell line propagated in the nude mouse.

The JOK-1 hairy cell leukemia derived cell line has been propagated as a subcutaneous tumor in nude mice. After the tumor had been serially transplanted for at least two successive generations, mice were treated with either dimethylsulfoxide or hexamethylene bisacetamide (HMBA). These agents have been shown to induce terminal leukemic cell differentiation in vitro. Our results indicated that these agents had an in vivo growth inhibitory effect, with HMBA exerting a dose-dependent response. Histopathological examination revealed massive areas of necrosis with no overt signs of cellular differentiation. These data suggest that in vitro inducers of differentiation may act via another mechanism in vivo.

Acetamides↗

Lack of natural killer cell activity in hairy cell leukemia patients and partial restoration with interleukin-2.

Natural Killer (NK) cell activity was studied in ten hairy cell leukemia (HCL) patients by means of a 4-hour cytotoxicity assay using mononuclear cells isolated from either the spleen or peripheral blood. Identical assays were performed on individuals who were either normal or had nonmalignant hematologic disorders. HCL patients had a significant decrease in NK cell activity at all effector-to-target ratios compared with the control group. Effects of interleukin-2 (IL-2) on NK activity were studied in four patients. After a 3-day in vitro incubation with IL-2, there was a marked increase in NK activity of mononuclear cells obtained from each of these patients. On the basis of the results it can be hypothesized that susceptibility to infections, which are commonly encountered in HCL patients, may be due in part to a low level of NK activity. Based on the apparent augmentation of NK activity in vitro, it might be of interest to initiate a clinical trial with IL-2 in patients with HCL.

Cell Separation↗